Headline News about Pfizer
Behind the Scenes of Pfizer's Latest Options Trends
October 03, 2024
Via Benzinga
Key Takeaways From Pfizer Analyst Ratings
October 03, 2024
Via Benzinga
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
October 07, 2024
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|